UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Gene expression profiles for the human pancreas and purified islets in Type 1 diabetes: new findings at clinical onset and in long-standing diabetes

Clinical and experimental immunology, 2010-01, Vol.159 (1), p.23-44

2010

Volltextzugriff (PDF)

Simeprevir in combination with sofosbuvir in treatment‐naïve and ‐experienced patients with hepatitis C virus genotype 4 infection: a Phase III, open‐label, single‐arm study (PLUTO)

Alimentary pharmacology & therapeutics, 2017-02, Vol.45 (3), p.468-475

2017

Volltextzugriff (PDF)

Scapular winging in surgical treatment of breast cancer, prospective study to optimize the follow-up protocol

Clinical & translational oncology, 2021-10, Vol.23 (10), p.2090-2098

2021

Volltextzugriff (PDF)

1081 NEW DIAGNOSTIC AND PROGNOSTIC PLASMA BIOMARKERS FOR PATIENTS WITH HEPATOCELLULAR CARCINOMA IDENTIFIED BY PROTEIN PROFILING

Journal of hepatology, 2013-04, Vol.58, p.S443-S443

2013

Volltextzugriff (PDF)

Dendritic cells pulsed with antigen-specific apoptotic bodies prevent experimental type 1 diabetes

Clinical and experimental immunology, 2010-05, Vol.160 (2), p.207-214

2010

Volltextzugriff (PDF)

Hepacontrol: A Program That Reduces Early Hospital Readmissions and Mortality among Patients with Decompensated Cirrhosis

Journal of hepatology, 2016, Vol.64 (2), p.S253-S254

2016

Volltextzugriff (PDF)

Impact of sustained virological response with DAAs in patients with compensated HCV cirrhosis and endoscopic esophageal varices study

Journal of hepatology, 2017, Vol.66 (1), p.S717-S717

2017

Volltextzugriff (PDF)

Simeprevir plus Sofosbuvir for Hepatitis C Virus Genotype 4 Infection: A Phase 3, Open-Label Study

Journal of hepatology, 2016, Vol.64 (2), p.S220-S221

2016

Volltextzugriff (PDF)

Platelet Count and Liver Stiffness Measurement to Exclude High-Risk Gastroesophageal Varices in Patients with HCV-Cirrhosis. A Multicentric Study

Journal of hepatology, 2016, Vol.64 (2), p.S273-S273

2016

Volltextzugriff (PDF)

Efficacy and Tolerability of Simeprevir and Daclatasvir for 12 or 24 Weeks in HCV Genotype 1b-Infected Treatment-Naïve Patients with Advanced Fibrosis or Compensated Cirrhosis

Journal of hepatology, 2016, Vol.64 (2), p.S754-S754

2016

Volltextzugriff (PDF)

Progression of liver fibrosis in HIV/hepatitis C virus‐coinfected individuals on antiretroviral therapy with early stages of liver fibrosis at baseline

HIV medicine, 2014-04, Vol.15 (4), p.203-212

2014

Volltextzugriff (PDF)

The Macrophage Protein CD5L Acts as a Pro-Oncogenic Factor in Hepatocytes

Journal of hepatology, 2016, Vol.64 (2), p.S565-S565

2016

Volltextzugriff (PDF)

Endoscopist experience as a risk factor for colonoscopic complications

Colorectal disease, 2010-10, Vol.12 (10Olie), p.e273-e277

2010

Volltextzugriff (PDF)

Comprehensive Proteomic Study of Hepatoblastoma: Identification of a Prognostic Signature and Deregulated Pathways

Journal of hepatology, 2016, Vol.64 (2), p.S302-S302

2016

Volltextzugriff (PDF)

Memory B Cells Activate Brain-Homing, Autoreactive CD4+ T Cells in Multiple Sclerosis

Cell, 2018-09, Vol.175 (1), p.85-100.e23

2018

Volltextzugriff (PDF)

P1201 UTILITY OF SERUM MARKERS AND TRANSIENT ELASTOGRAPHY TO IDENTIFY SERIOUS ADVERSE EFFECTS DURING ANTIVIRAL THERAPY IN HCV INFECTED CIRRHOTIC PATIENTS. A MULTICENTER STUDY

Journal of hepatology, 2014-04, Vol.60 (1), p.S488-S488

2014

Volltextzugriff (PDF)

Natural killer cells are required for accelerated type 1 diabetes driven by interferon-β

Clinical and experimental immunology, 2008-03, Vol.151 (3), p.467-475

2008

Volltextzugriff (PDF)

Liver injury induced by "natural remedies": an analysis of cases submitted to the Spanish Liver Toxicity Registry

Revista española de enfermedades digestivas, 2008-11, Vol.100 (11), p.688

2008

Volltextzugriff (PDF)

1378 EFFECT OF ABCC2 HAPLOTYPES ON INDIOSYNCRATIC DRUG-INDUCED LIVER INJURY (DILI) SUSCEPTIBILITY

Journal of hepatology, 2012-04, Vol.56, p.S541-S541

2012

Volltextzugriff (PDF)

P1299 PEARL-III: 12 WEEKS OF ABT-450/R/267 + ABT-333 ACHIEVED SVR IN >99% OF 419 TREATMENT-NAIVE HCV GENOTYPE 1B-INFECTED ADULTS WITH OR WITHOUT RIBAVIRIN

Journal of hepatology, 2014-04, Vol.60 (1), p.S527-S527

2014

Volltextzugriff (PDF)

Randomized trial comparing albumin, dextran 70, and polygeline in cirrhotic patients with ascites treated by paracentesis

Gastroenterology (New York, N.Y. 1943), 1996-10, Vol.111 (4), p.1002-1010

1996

Volltextzugriff (PDF)

1154 PEGINTERFERON ALPHA-2A ACHIEVES HIGHER EARLY VIROLOGICAL RESPONSES (RVR AND CEVR) THAN PEGINTERFERON ALPHA-2B IN CHRONIC HEPATITIS C: META-ANALYSIS OF RANDOMIZED CLINICAL TRIALS (RCT)

Journal of hepatology, 2012-04, Vol.56, p.S456-S456

2012

Volltextzugriff (PDF)

1138 PRETREATMENT VIRAL GENETIC FACTORS IMPROVE IL28B PREDICTIONS OF VIROLOGIC RESPONSE TO STANDARD THERAPY IN HEPATITIS C VIRUS 1B INFECTED PATIENTS

Journal of hepatology, 2012-04, Vol.56, p.S449-S449

2012

Volltextzugriff (PDF)

253 EPCAM AND AFP AS POOR PROGNOSTIC MARKERS IN PATIENTS WITH HEPATOBLASTOMA

Journal of hepatology, 2012-04, Vol.56, p.S106-S107

2012

Volltextzugriff (PDF)

β blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial

The Lancet (British edition), 2019-04, Vol.393 (10181), p.1597-1608

2019

Volltextzugriff (PDF)

1 – 25 von 1.146

Suche als RSS-Feed

Aktive Filter

ThemaGastroenterology. Liver. Pancreas. Abdomen

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(949)
Mit Volltextzugriff
(961)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(532)
Life Sciences & Biomedicine
(464)
Humans
(409)
Male
(291)
Female
(255)
Middle Aged
(188)
Biological And Medical Sciences
(175)
Adult
(152)
Aged
(129)
Medical Sciences
(126)
Animals
(100)
Gastroenterology & Hepatology
(66)
Fundamental And Applied Biological Sciences. Psychology
(65)
Infectious Diseases
(51)
Physical Sciences
(51)
General & Internal Medicine
(46)
Adolescent
(45)
Prospective Studies
(45)
Pharmacology. Drug Treatments
(44)
Biochemistry & Molecular Biology
(43)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Gene expression profiles for the human pancreas and purified islets in Type 1 diabetes: new findings at clinical onset and in long-standing diabetes

Simeprevir in combination with sofosbuvir in treatment‐naïve and ‐experienced patients with hepatitis C virus genotype 4 infection: a Phase III, open‐label, single‐arm study (PLUTO)

Scapular winging in surgical treatment of breast cancer, prospective study to optimize the follow-up protocol

1081 NEW DIAGNOSTIC AND PROGNOSTIC PLASMA BIOMARKERS FOR PATIENTS WITH HEPATOCELLULAR CARCINOMA IDENTIFIED BY PROTEIN PROFILING

Dendritic cells pulsed with antigen-specific apoptotic bodies prevent experimental type 1 diabetes

Hepacontrol: A Program That Reduces Early Hospital Readmissions and Mortality among Patients with Decompensated Cirrhosis

Impact of sustained virological response with DAAs in patients with compensated HCV cirrhosis and endoscopic esophageal varices study

Simeprevir plus Sofosbuvir for Hepatitis C Virus Genotype 4 Infection: A Phase 3, Open-Label Study

Platelet Count and Liver Stiffness Measurement to Exclude High-Risk Gastroesophageal Varices in Patients with HCV-Cirrhosis. A Multicentric Study

Efficacy and Tolerability of Simeprevir and Daclatasvir for 12 or 24 Weeks in HCV Genotype 1b-Infected Treatment-Naïve Patients with Advanced Fibrosis or Compensated Cirrhosis

Progression of liver fibrosis in HIV/hepatitis C virus‐coinfected individuals on antiretroviral therapy with early stages of liver fibrosis at baseline

The Macrophage Protein CD5L Acts as a Pro-Oncogenic Factor in Hepatocytes

Endoscopist experience as a risk factor for colonoscopic complications

Comprehensive Proteomic Study of Hepatoblastoma: Identification of a Prognostic Signature and Deregulated Pathways

Memory B Cells Activate Brain-Homing, Autoreactive CD4+ T Cells in Multiple Sclerosis

P1201 UTILITY OF SERUM MARKERS AND TRANSIENT ELASTOGRAPHY TO IDENTIFY SERIOUS ADVERSE EFFECTS DURING ANTIVIRAL THERAPY IN HCV INFECTED CIRRHOTIC PATIENTS. A MULTICENTER STUDY

Natural killer cells are required for accelerated type 1 diabetes driven by interferon-β

Liver injury induced by "natural remedies": an analysis of cases submitted to the Spanish Liver Toxicity Registry

1378 EFFECT OF ABCC2 HAPLOTYPES ON INDIOSYNCRATIC DRUG-INDUCED LIVER INJURY (DILI) SUSCEPTIBILITY

P1299 PEARL-III: 12 WEEKS OF ABT-450/R/267 + ABT-333 ACHIEVED SVR IN >99% OF 419 TREATMENT-NAIVE HCV GENOTYPE 1B-INFECTED ADULTS WITH OR WITHOUT RIBAVIRIN

Randomized trial comparing albumin, dextran 70, and polygeline in cirrhotic patients with ascites treated by paracentesis

1154 PEGINTERFERON ALPHA-2A ACHIEVES HIGHER EARLY VIROLOGICAL RESPONSES (RVR AND CEVR) THAN PEGINTERFERON ALPHA-2B IN CHRONIC HEPATITIS C: META-ANALYSIS OF RANDOMIZED CLINICAL TRIALS (RCT)

1138 PRETREATMENT VIRAL GENETIC FACTORS IMPROVE IL28B PREDICTIONS OF VIROLOGIC RESPONSE TO STANDARD THERAPY IN HEPATITIS C VIRUS 1B INFECTED PATIENTS

253 EPCAM AND AFP AS POOR PROGNOSTIC MARKERS IN PATIENTS WITH HEPATOBLASTOMA

β blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial

Aktive Filter

Suchergebnisse filtern